DELRAY BEACH, Fla., April 24, 2014 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that its teaming partner Leidos (f/k/a/ Science Applications International Corporation) was awarded a prime contract by the U.S. Defense Threat Reduction Agency (“DTRA”) to conduct research and development to combat weapons of mass destruction. The multiple-award indefinite delivery/indefinite quantity (“ID/IQ”) contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised. The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract.
Help employers find you! Check out all the jobs and post your resume.
